Literature DB >> 35023271

Rapid onset of response to sonidegib for multiple facial basal cell carcinomas during COVID-19 pandemic.

Sabiha Trabelsi1, Fawaz Khidher1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35023271     DOI： 10.1111/dth.15317

Source DB:  PubMed          Journal:  Dermatol Ther        ISSN： 1396-0296            Impact factor:   2.851


× No keyword cloud information.
  2 in total

1.  Experience with sonidegib in patients with advanced basal cell carcinoma: case reports.

Authors:  Susana Puig; Carlos Serra-Guillén; Gemma Pérez-Pastor; Álvaro Martínez-Domenech; Ricardo Fernández-de-Misa Cabrera
Journal:  Drugs Context       Date:  2022-05-23

2.  Sonidegib-induced muscle spasms in the treatment of basal cell carcinoma: Strategies to adopt.

Authors:  Alessia Villani; Gabriella Fabbrocini; Massimiliano Scalvenzi
Journal:  Dermatol Ther       Date:  2022-04-29       Impact factor: 3.858
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.